Category IP Policies

Proposal Could Create New Biotech Benefits In WHO Public Medicine System

By Tove Iren S. Gerhardsen The biotechnology industry has proposed to change the international generic naming of medicine ingredients, which at the moment are public property, into unique names for each medicine, making it harder to substitute them with cheaper…

Developed Country Strategy On WIPO Development Agenda, Governance Revealed

By Tove Iren S. Gerhardsen and William New The report from a September meeting of the World Intellectual Property Organization (WIPO) developed country group reveals its behind-the-scenes strategy for handling a proposed development agenda at WIPO. The WIPO General Assembly…